There was no significant difference in TMB between the two tumor entities; astrocytoma exhibited higher mutation rates of ATRX and TP53, and oligodendroglioma presented higher mutated rates of TERT, PTEN and PIK3CA (Fig. 1G, H). The gene discussed is TP53; the disease is neoplasm.